Congress Programme

Day 2 June 4

Time	Session

07:30 08:30	Registration
08:30 10:00	Plenary Session 3: Pain in Sickle Cell Disease Kalpna Gupta Co-Chair Prof Wally Smith Co-Chair
10:00 10:30	Break
10:30 12:00	Parallel Session 4: Clinical Variability and Genetic Modifiers of Sickle Cell Disease David Rees Co-Chair Stephan Menzel Co-Chair	Parallel Session 5: Benefits and Challenges of Transfusion Therapy in Sickle Cell Disease Prof Saliou Diop Co-Chair Rafaella Columbatti Co-Chair	Parallel Session 6: Women’s Health in Sickle Cell Disease Bosede Afolabi Co-Chair Dr Eugenia Vicky Asare Co-Chair
12:00 13:00	Lunch
13:00 14:30	Parallel Session 7: Co-morbidities Impacting the Severity of Sickle Cell Disease Anazoeze Madu Co-Chair GUINDO Aldiouma Co-Chair	Parallel Session 8: End-Organ Damage and Co-morbidities in Sickle Cell Disease Fred Sarfo Co-Chair Jennifer Knight-Madden Co-Chair	Parallel Session 9: Public Health/Implementation Science in Sickle Cell Disease Dr Maureen Achebe Co-Chair Kofi Nyako Co-Chair
14:30 15:00	Break
15:00 16:30	Parallel Session 10: Health Care Transitions in Sickle Cell Disease Biobele Brown Co-Chair Prof Jane Hankins Co-Chair	Parallel Session 11: Increasing Knowledge of Patients and Community About Sickle Cell Disease Lakshmanan Krishnamurti Co-Chair Lewis Hsu Co-Chair	Parallel Session 12: Creating Healthcare Capacity Through Education and Training in Sickle Cell Disease Prof Olivat Rakoto Co-Chair Yvonne Carroll Co-Chair
16:30 17:30	Symposium 3: Pharma Sponsored Symposium- Agios Pharmaceuticals
17:30 19:00	Poster Sessions
19:30 20:30	Dinner Symposium 4: Pharma Sponsored Symposium Sponsored by: Novo Nordisk Rare Diseases